This site is intended for healthcare professionals
  • Home
  • /
  • Event
  • /
  • Novartis sponsored satellite symposium at the 7th ...
EAN Congress

Novartis sponsored satellite symposium at the 7th Congress of the European Academy of Neurology

Partnering with patients from the start of the MS journey: Priorities, practicalities and progress

  • Event type:
    EAN Congress
  • Date
    20 Jun 2021 - 20 Jun 2021
  • Location
Register directly with EAN virtual congress

Sunday 20th June 2021 | 12:15 – 13:00 CEST

During the 7th Congress of the European Academy of Neurology (EAN), Novartis is excited to invite you to the satellite symposium: Partnering with patients from the start of the MS Journey: Priorities practicalities and progress. Hear from the panel of experts, chaired by Caroline Wyatt, a British journalist living with MS, as they discuss the latest advances in MS management and treatment that are improving outcomes for people living with MS (PLwMS).

 

Highlights of the event will be available here on Medthority following the event so make sure you register an interest to receive notifications for the OnDemand sessions.

Hear the speakers discuss below what you can expect from the symposium.

Register an interest in the symposium and receive updates up our EAN coverage with Medthority

An error has occurred while getting captcha image

To explore further Novartis supported educational content please visit the One Neuroscience & Pain Learning Zone click here.

By clicking the “Sign Up” button you confirm you are happy to receive further information about this symposium and related Medthority updates. To attend this event, you must register directly with EAN virtual congress: www.eanvirtualcongress.org

Symposium agenda

Partnering with patients from the start of the MS journey: Priorities, practicalities and progress?
Sunday 20th June 2021 | 12:15 – 13:00 CEST
Welcome and introduction Caroline Wyatt, UK
Advances in therapy and improved long-term outcomes: Time to reappraise? Ralf Linker, Germany
Managing MS in a unique era: New contexts and new challenges Stephen Yeung, USA
Advances in MS therapy: Are we improving the patient’s experience? Colleen Harris, Canada
Live Q&A All

Add event to calendar

Apple Google Office 365 Outlook Outlook.com Yahoo

Developed by EPG Health for Medthority. This content has been developed in collaboration with Novartis Pharma AG. EPG Health received funding from Novartis Pharma AG in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non- Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country. FUSE ID: 133522 (June 2021).